
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
What are parents to do as doctors clash with Trump administration over vaccines? - 2
Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech - 3
Wegovy maker Novo sharpens consumer focus with board role for Mars CEO - 4
The Best Computer games for Multiplayer Fun - 5
Opening Achievement: 8 Methodologies for Compelling Using time productively
Machado ‘presented’ her Nobel Peace Prize medal to Trump
Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem
Africa's energy giants eye long-term gains on Iran war disruption
The hunt for dark matter: a trivia quiz
France honors the victims of the Paris attacks' night of terror 10 years on
Second doctor in Matthew Perry overdose case sentenced to home confinement
This Week In Space podcast: Episode 192 — Space, 2026!
Former GLP-1 users regain lost weight after about 18 months, study says
A Manual for Pick Great Lawful Discussion Administrations For New businesses In 2024












